Related references
Note: Only part of the references are listed.Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors
Eva Martinez-Pinilla et al.
FRONTIERS IN PHARMACOLOGY (2017)
Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease
Alexandre Vallee et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Synaptic Mechanisms of Adenosine A2A Receptor-Mediated Hyperexcitability in the Hippocampus
Diogo M. Rombo et al.
HIPPOCAMPUS (2015)
Cannabidiol Normalizes Caspase 3, Synaptophysin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection
Vanessa Kappel da Silva et al.
MOLECULAR NEUROBIOLOGY (2014)
Synaptic plasticity in health and disease: introduction and overview
T. V. P. Bliss et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1aΔE9 mice
David Cheng et al.
PSYCHOPHARMACOLOGY (2014)
Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity
Andrew J. Nicoll et al.
NATURE COMMUNICATIONS (2013)
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
Alison Ribeiro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
The therapeutic potential of the endocannabinoid system for Alzheimer's disease
Tim Karl et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
Elen V. Fagherazzi et al.
PSYCHOPHARMACOLOGY (2012)
Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways
C. J. Ledgerwood et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
George W. Booz
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
Ana Maria Martin-Moreno et al.
MOLECULAR PHARMACOLOGY (2011)
Aβ1-42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β
Jihoon Jo et al.
NATURE NEUROSCIENCE (2011)
Cannabidiol Reduces Ab- Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
Giuseppe Esposito et al.
PLOS ONE (2011)
Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites
Darragh B. Freir et al.
NATURE COMMUNICATIONS (2011)
The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia
Jessica M. Mc Donald et al.
BRAIN (2010)
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
T. V. Zanelati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Control of Cannabinoid CB1 Receptor Function on Glutamate Axon Terminals by Endogenous Adenosine Acting at A1 Receptors
Alexander F. Hoffman et al.
JOURNAL OF NEUROSCIENCE (2010)
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors
A. Castillo et al.
NEUROBIOLOGY OF DISEASE (2010)
5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
Leonardo B. M. Resstel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Time-dependent vascular actions of cannabidiol in the rat aorta
Saoirse E. O'Sullivan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Cannabidiol Targets Mitochondria to Regulate Intracellular Ca2+ Levels
Duncan Ryan et al.
JOURNAL OF NEUROSCIENCE (2009)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2008)
Mediation of Cannabidiol Anti-inflammation in the Retina by Equilibrative Nucleoside Transporter and A2A Adenosine Receptor
Gregory I. Liou et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences
J. M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties
M. Amine Bouhlel et al.
CELL METABOLISM (2007)
PPARs in the brain
Michael T. Heneka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway
Ganesh M. Shankar et al.
JOURNAL OF NEUROSCIENCE (2007)
UP inhibits LTD in the hippocampus via regulation of GSK3β
Stephane Peineau et al.
NEURON (2007)
Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression
Erica J. Carrier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement
Giuseppe Esposito et al.
NEUROSCIENCE LETTERS (2006)
The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells
G Esposito et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Endocannabinoids restrict hippocampal long-term potentiation via CB1
KA Slanina et al.
NEUROPHARMACOLOGY (2005)
Agonists of peroxisome proliferator-activated receptor-γ attenuate the Aβ-mediated impairment of LTP in the hippocampus in vitro
DA Costello et al.
NEUROPHARMACOLOGY (2005)
Peroxisome proliferator-activated receptor γ is expressed in hippocampal neurons and its activation prevents β-amyloid neurodegeneration:: role of Wnt signaling
NC Inestrosa et al.
EXPERIMENTAL CELL RESEARCH (2005)
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells
T Iuvone et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Adenosine: an endogenous regulator of innate immunity
G Hasko et al.
TRENDS IN IMMUNOLOGY (2004)
Amnesia induced by β-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade
C Mazzola et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Neuroprotection by caffeine and adenosine A2A receptor blockade of β-amyloid neurotoxicity
OP Dall'lgna et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662
LM Leesnitzer et al.
BIOCHEMISTRY (2002)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Adenosine and synaptic plasticity
A de Mendoncca et al.
DRUG DEVELOPMENT RESEARCH (2001)
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
DM Holtzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
